Citations (15)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
L. Christiansen, J. Brøns‐Poulsen, M. Hørder, A. Brock & N. E. Petersen. (2005) Expression and characterization of six clinically relevant uroporphyrinogen decarboxylase gene mutations. Scandinavian Journal of Clinical and Laboratory Investigation 65:3, pages 227-235.
Read now
Read now
Articles from other publishers (14)
Muhammad Awais, Javed Iqbal Wattoo, Rimsha Zafar & Naveera Khan. (2021) Computational analysis of non-synonymous single nucleotide polymorphism in UROD gene linked with familial Porphyria Cutanea Tarda. Gene Reports 25, pages 101413.
Crossref
Crossref
Sara Gómez-Abecia, María-Josefa Morán-Jiménez, Eva Ruiz-Casares, Nuno Henriques-Gil, Inmaculada García-Pastor, María-Concepción Garrido-Astray, Rafael Enríquez de Salamanca & Manuel Méndez. (2013) Familial porphyria cutanea tarda in Spain: Characterization of eight novel mutations in the UROD gene and haplotype analysis of the common p.G281E mutation. Gene 522:1, pages 89-95.
Crossref
Crossref
Alice Rudd, Janine Grant, George Varigos, Vanessa Morgan & Ingrid Winship. (2013) Co-existence of hereditary coproporphyria and porphyria cutanea tarda: The importance of genetic testing. Australasian Journal of Dermatology 54:2, pages e50-e52.
Crossref
Crossref
Manuel Méndez, María Victoria Rossetti, Sara Gómez-Abecia, María-Josefa Morán-Jiménez, Victoria Parera, Alcira Batlle & Rafael Enríquez de Salamanca. (2012) Molecular analysis of the UROD gene in 17 Argentinean patients with familial porphyria cutanea tarda: Characterization of four novel mutations. Molecular Genetics and Metabolism 105:4, pages 629-633.
Crossref
Crossref
Andrew G. SmithGeorge H. Elder. (2010) Complex Gene−Chemical Interactions: Hepatic Uroporphyria As a Paradigm. Chemical Research in Toxicology 23:4, pages 712-723.
Crossref
Crossref
Aasne K Aarsand, Helge Boman & Sverre Sandberg. (2009) Familial and Sporadic Porphyria Cutanea Tarda: Characterization and Diagnostic Strategies. Clinical Chemistry 55:4, pages 795-803.
Crossref
Crossref
M. Méndez, P. Poblete-Gutiérrez, M. García-Bravo, T. Wiederholt, M.J. Morán-Jiménez, H.F. Merk, M.C. Garrido-Astray, J. Frank, A. Fontanellas & R. Enríquez de Salamanca. (2007) Molecular heterogeneity of familial porphyria cutanea tarda in Spain: characterization of 10 novel mutations in the UROD gene. British Journal of Dermatology 157:3, pages 501-507.
Crossref
Crossref
Shigeru Sassa. (2006) Modern diagnosis and management of the porphyrias. British Journal of Haematology 135:3, pages 281-292.
Crossref
Crossref
Ingrid Rossmann‐Ringdahl & Rolf Olsson. (2005) Porphyria Cutanea Tarda in a Swedish Population: Risk Factors and Complications. Acta Dermato-Venereologica 85:4, pages 337-341.
Crossref
Crossref
Pamela Poblete-Gutierrez, Manuel Mendez, Tonio Wiederholt, Hans F. Merk, Antonio Fontanellas, Carlos Wolff & Jorge Frank. (2004) The molecular basis of porphyria cutanea tarda in Chile: Identification and functional characterization of mutations in the uroporphyrinogen decarboxylase gene. Experimental Dermatology 13:6, pages 372-379.
Crossref
Crossref
G.H. ELDER. 2003. The Porphyrin Handbook. The Porphyrin Handbook
67
92
.
Wolfgang Jessner, Manon Der-Petrossian, Lene Christiansen, Harald Maier, Petra Steindl-Munda, Alfred Gangl & Peter Ferenci. (2002) Porphyria cutanea tarda during interferon/ribavirin therapy for chronic hepatitis C. Hepatology 36:5, pages 1301-1302.
Crossref
Crossref
Lene Christiansen, Anette Bygum, Marianne Käehne, Alice Jensen, Mogens Hørder & Niels Erik Petersen. (2001) Mutation Screening of the Entire Coding Region of the Protoporphyrinogen Oxidase Gene Using Denaturing Gradient Gel Electrophoresis and Denaturing HPLC. Clinical Chemistry 47:6, pages 1115-1117.
Crossref
Crossref
L. Christiansen, A. Bygum, A. Jensen, K. Thomsen, F. Brandrup, M. Hørder & N. E. Petersen. (2000) Association between CYP1A2 polymorphism and susceptibility to porphyria cutanea tarda. Human Genetics 107:6, pages 612-614.
Crossref
Crossref